autologous PBSC transplant

PROCEDURE2 trials

Sponsors

Centre National de Greffe de Moelle Osseuse, Emory University

Conditions

CancerMultiple Myeloma

Phase 1

Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

TerminatedNCT00793650

Emory UniversityCancer, Multiple Myeloma

Start: 2005-05-31End: 2011-09-30Updated: 2012-08-30

Phase 3

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

CompletedNCT00207805

Centre National de Greffe de Moelle OsseuseMultiple Myeloma

Start: 2003-05-31Target: 202Updated: 2009-01-27